Advances in Social Science, Education and Humanities Research, volume 666 Proceedings of the 2022 International Conference on Science and Technology Ethics and Human Future (STEHF 2022) Advantages and Challenges of Roller Compaction Process for Dry Granulation * Feiyang Wu Xi 'an Jiaotong Liverpool University, Suzhou, 215400, China *Corresponding author. Email: Feiyang.wu20@student.xjtlu.edu.cn ABSTRACT Granulation, which is a technology of expanding particles by coagulation, is one of the most significant unit operations for the production of drug ...
Research and Reviews: Journal of Pharmacology and Toxicological Studies e-ISSN:2322-0139 p-ISSN:2322-0120 Tablets Manufacturing Methods and Granulation Techniques Sravya I* Department of Biotechnology , Gokaraju Rangaraju Institute of Engineering and Technology, Hyderabad, Telangana, India Review Article Received: 26/09/2016 Accepted: 28/09/2016 Published: 30/09/2016 ABSTRACT *Corresponding author: From past hundred years tablet manufacturers have developed materials and processes that can produce compressed tablets Sravya I, Department of Biotechnology, containing a precise amount of an active pharmaceutical Gokaraju Rangaraju Institute of Engineering ingredient (API) at ...
Shanmugam, BioImpacts, 2015, 5(1), 55-63 doi: 10.15171/bi.2015.04 TUOMS http://bi.tbzmed.ac.ir/ Publishing BioImpacts Group Publish Free ccess Granulation techniques and technologies: recent progresses Srinivasan Shanmugam* Pharm. R&D Institute, Hanmi Pharm. Co., Ltd., Hwasung, Gyeonggi, Korea Article Type Abstract Granulation, the process of particle enlargement by agglomeration technique, is one of the most significant unit operations in the production of pharmaceutical dosage forms, mostly tablets and capsules. Granulation process transforms fine powders into free-flowing, dust- ...
1 Data Sheet MAY GRUNWALD GIEMSA For smears Blood smear CODE DESCRIPTION TESTS NUMBER 04-080802 May Grunwald Giemsa for smears 50 working solutions (100 ml each) In Vitro Diagnostic – medical device Manufacturer: Bio-Optica Milano S.p.A. IVD in Class A, Reg. UE 2017/746 UDI-DI: 08033976230951 Basic UDI: 080339762W01030799Y5 Bio-Optica Milano S.p.A. Via San Faustino 58 - 20134 Milano Phone +39 02.21.27.13.1 - Fax Italia +39 02.21.53.000 - Fax Export ...
PDF | 0.19 MB | Free Download
